187
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Evaluating the process parameters of the dry coating process using a 25-1 factorial design

&
Pages 39-45 | Received 08 Dec 2009, Accepted 16 Jun 2010, Published online: 19 Aug 2011

References

  • Wheatley TA, Steuernagel CR (1997). Latex emulsions for controlled drug delivery In: James W. McGinity. Aqueous Polymeric Coatings for Pharmaceutical dosage forms. New York: Marcel Dekker, 1–54.
  • Kablitz CD, Harder K, Urbanetz NA. Dry coating in a rotary fluid bed. Eur J Pharm Sci 2006;27:212–219.
  • Obara S, Maruyama N, Nishiyama Y, Kokubo H. Dry coating: an innovative enteric coating method using a cellulose derivative. Eur J Pharm Biopharm 1999;47:51–59.
  • Cerea M, Zheng W, Young CR, McGinity JW. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets. Int J Pharm 2004;279:127–139.
  • Zheng WJ, Cerea M, Sauer D, McGinity JW. Properties of theophylline tablets powder-coated with methacrylate ester copolymers. J Drug Deliv Sci Technol 2004;14:319–325.
  • Pearnchob N, Bodmeier R. Dry polymer powder coating and comparison with conventional liquid-based coatings for Eudragit) RS, ethylcellulose and shellac. Eur J Pharm Biopharm 2003;56:363–369.
  • Pearnchob N, Bodmeier R. Dry powder coating of pellets with micronized Eudragit RS for extended drug release. Pharm Res 2003;20:1970–1976.
  • Pearnchob N, Bodmeier R. Coating of pellets with micronized ethylcellulose particles by a dry powder coating technique. Int J Pharm 2003;268:1–11.
  • Genovesi A, Spadoni A, Funaro C, Vecchio C. Evaluation of a Novel Dry Coating Method using Powder Layering GS— IMA Technology. Proc 4th World Meeting ADRITELF/APGI/APV, Florence, Italy, 2002.
  • Maejima T, McGinity JW. Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers. Pharm Dev Technol 2001;6:211–221.
  • Kablitz CD, Urbanetz NA. Characterization of the film formation of the dry coating process. Eur J Pharm Biopharm 2008;69:1760–768.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.